The XXIII Winter Meeting of the Spanish Society of Pulmonology and Thoracic Surgery (Separ) provided a platform for healthcare professionals to discuss the updated clinical guidelines for pulmonary hypertension. The guidelines, which were last updated in 2015, have now been revised to revolutionize the approach to this pathology. The changes have been the subject of discussion and debate among researchers, professionals, and patients at the meeting.
Ernest Sala, Head of the Pulmonology Service at Son Espases Hospital, emphasized that the updated guidelines have significantly impacted the therapeutic algorithm for pulmonary hypertension. He pointed out that the new document includes changes in the definition of the disease and the scale to detect it, addressing the need for early diagnosis and treatment. However, he also highlighted that the therapeutic algorithm has both positive and negative aspects, with some areas requiring more evidence.
Pilar Escribano, a specialist in cardiology, expressed optimism about the current approach to pulmonary hypertension, citing the emergence of new therapeutic options on the horizon. However, she emphasized the need for trials involving older populations to ensure the effectiveness of new drugs. Escribano also stressed the importance of considering comorbidities in the approach to pulmonary hypertension, which has been a challenging aspect of the therapeutic algorithm.
Amaya Martínez, a pulmonologist and coordinator of the Pulmonary Circulation area of Separ, echoed similar sentiments, suggesting that the future may hold the possibility of combined treatment involving multiple drugs for pulmonary hypertension. She pointed out that existing trials often exclude patients with comorbidities, limiting the information available for treating these individuals.
From a nursing perspective, Ana María Ramírez, a nurse at the Pulmonary Hypertension Unit of the Hospital Clínic of Barcelona, emphasized the need for specific questionnaires to address the individual needs of patients with pulmonary hypertension. She also highlighted the importance of psychological and psychiatric referral, patient education, and adherence to treatment.
Overall, the updated clinical guidelines for pulmonary hypertension have sparked conversations and debates among healthcare professionals, highlighting the need for continued research and a personalized approach to treatment. This information, although containing statements, data, or notes from health institutions or professionals, has been prepared and edited by journalists. Readers are advised to consult with healthcare professionals for any health-related questions.